首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1490104

全球過敏治療市場：按類型、治療、分銷管道、地區

Allergy Treatment Market, By Type, By Treatment, By Distribution Channel, By Geography

出版日期: 2024年05月17日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球過敏治療市場規模預計將從2024年的211.9億美元增加到2031年的344.2億美元，2024-2031年年複合成長率為7.2%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	211.9億美元
實際資料	2019-2023	預測期	2024-2031
預測期 2024-2031 年年複合成長率	7.20%	2031年價值預測	344.2億美元

圖：2024 年按地區分類的過敏治療市場佔有率(%)

由於全球過敏性疾病盛行率不斷上升，全球過敏治療市場在過去幾年中出現了顯著成長。當免疫系統對灰塵、花粉和黴菌等環境過敏原反應過度時，就會引起過敏性疾病。據最近估計，全球有超過10億人患有過敏性鼻炎。此外，污染水平的上升和生活方式的改變進一步增加了過敏的風險。因此，對有效治療方案的需求不斷成長，以控制各種過敏性疾病的症狀，包括抗組織胺、減充血劑、皮質類固醇和過敏原免疫療法。

市場動態：

全球過敏治療市場受到污染水平上升、氣候條件變化以及新興國家醫療保健支出增加等因素的推動。然而，農村地區過敏治療意識淡薄以及免疫治療成本高昂限制了市場成長。開發具有改善功效的新型治療劑為市場提供了利潤豐厚的機會。各大公司都專注於研發先進的治療方法來解決抗藥性問題。然而，有關新過敏藥物核准的嚴格規定是一個問題。

本研究的主要特點

本報告對全球過敏治療藥物市場進行了詳細分析，並提出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還強調了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
基於公司亮點、產品系列、主要亮點、績效和策略等參數的全球過敏治療市場主要企業的概況。
主要企業包括賽諾菲、諾華、葛蘭素史克、強生服務公司、羅氏公司、Stallergenes Greer、Dermapharm Holding SE、Nicox、Allergy Therapeutics、艾伯維公司、梯瓦製藥工業有限公司，其中包括Alembic Pharmaceuticals Limited 、ALK-Abello A/S、Bausch Health Companies Inc.、GLENMARK PHARMACEUTICALS LTD.、Perrigo Company plc、Dr Reddy's Laboratories Ltd.
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球過敏治療市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過用於分析全球過敏治療市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Sanofi
- Novartis
- GSK plc
- Johnson &Johnson Services, Inc.
- F. Hoffmann-La Roche Ltd.
- Stallergenes Greer
- Dermapharm Holding SE
- Nicox
- Allergy Therapeutics
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Alembic Pharmaceuticals Limited
- ALK-Abello A/S
- Bausch Health Companies Inc.
- GLENMARK PHARMACEUTICALS LTD.
- Perrigo Company plc
- Dr Reddy's Laboratories Ltd.

第10章分析師的觀點

Wheel of Fortune
分析師觀點
Coherent Opportunity Map（COM）

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5143

The global allergy treatment market is estimated to be valued at USD 21.19 Bn in 2024 and is expected to reach USD 34.42 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 21.19 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	7.20%	2031 Value Projection:	US$ 34.42 Bn

Figure. Allergy Treatment Market Share (%), By Region, 2024

The global allergy treatment market has been witnessing significant growth over the past few years owing to the rising prevalence of allergic disorders worldwide. Allergic disorders are caused when the immune system overreacts to environmental allergens such as dust, pollen, mold, etc. According to recent estimates, over 1 billion people globally suffer from allergic rhinitis. Additionally, the rising levels of pollution and changed lifestyle habits have further increased the risk of developing allergies. As a result, there has been a growing demand for effective treatment options such as antihistamines, decongestants, corticosteroids, and allergen immunotherapy for managing the symptoms of various allergic conditions.

Market Dynamics:

The global allergy treatment market is driven by factors such as increasing pollution levels, changing climate conditions, and rising healthcare expenditure in developing nations. However, the lack of awareness about allergy treatment in rural areas and high costs associated with immunotherapy restrain the market growth. The development of novel therapeutic drugs with improved efficacy offers lucrative opportunities in the market. Key players are focusing on R&D to develop advanced treatment regimens for tackling drug resistance issues. However, stringent regulations for approval of new allergy drugs pose a challenge

Key Features of the Study:

This report provides an in-depth analysis of the global allergy treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global allergy treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Sanofi, Novartis, GSK plc, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abello A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, and Dr Reddy's Laboratories Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global allergy treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy treatment market.

Detailed Segmentation-

By Type:
- Eye Allergy
- Asthma
- Rhinitis
- Skin Allergy
- Food Allergies
- Others
By Treatment:
- Anti-allergy Drugs
- Immunotherapy
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Sanofi
- Novartis
- GSK plc
- Johnson & Johnson Services, Inc.
- Hoffmann-La Roche Ltd.
- Stallergenes Greer
- Dermapharm Holding SE
- Nicox
- Allergy Therapeutics
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Alembic Pharmaceuticals Limited
- ALK-Abello A/S
- Bausch Health Companies Inc.
- GLENMARK PHARMACEUTICALS LTD.
- Perrigo Company plc
- Dr Reddy's Laboratories Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Treatment
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Epidemiology
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Allergy Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Allergy Treatment Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Eye Allergy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Asthma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Rhinitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Skin Allergy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Food Allergies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Allergy Treatment Market, By Treatment, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Anti-allergy Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Allergy Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Allergy Treatment Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Stallergenes Greer
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dermapharm Holding SE
- Nicox
- Allergy Therapeutics
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Alembic Pharmaceuticals Limited
- ALK-Abello A/S
- Bausch Health Companies Inc.
- GLENMARK PHARMACEUTICALS LTD.
- Perrigo Company plc
- Dr Reddy's Laboratories Ltd.